Streetbeat News

Analyst Ratings

DRI

Darden Restaurants, Inc. (NYSE:DRI) reported weaker-than-expected Q1 results, missing both earnings and sales estimates. Despite this, the company announced a quarterly dividend and saw its stock price rise by 8.3%. Analysts have revised their price targets, with mixed ratings ranging from Hold to Outperform.

Portfolio Pulse from Avi Kapoor

September 20, 2024 | 12:40 pm

LTC

Wedbush analyst Richard Anderson has reiterated an Outperform rating for LTC Properties, maintaining a price target of $40.

Portfolio Pulse from Benzinga Newsdesk

September 20, 2024 | 12:40 pm

TIGO

Scotiabank has upgraded Millicom Intl Cellular (NASDAQ:TIGO) from Sector Perform to Sector Outperform, raising the price target from $30 to $37.3.

Portfolio Pulse from Benzinga Newsdesk

September 20, 2024 | 12:39 pm

TIMB

Scotiabank has upgraded TIM (NYSE:TIMB) from Sector Perform to Sector Outperform and increased its price target from $17.5 to $24.8.

Portfolio Pulse from Benzinga Newsdesk

September 20, 2024 | 12:37 pm

ACET

Wedbush analyst Robert Driscoll has reiterated an 'Outperform' rating for Adicet Bio (NASDAQ:ACET) and maintained a price target of $5.

Portfolio Pulse from Benzinga Newsdesk

September 20, 2024 | 12:37 pm

AZO

CBRL

DRI

FDX

NKE

TEX

Top Wall Street analysts have updated their price targets and ratings for several companies. Notably, Morgan Stanley downgraded FedEx, Loop Capital reduced Cracker Barrel's target, and Goldman Sachs cut Terex's target. Meanwhile, Baird raised Nike's target, and TD Cowen increased Darden Restaurants' target.

Portfolio Pulse from Avi Kapoor

September 20, 2024 | 12:34 pm

TRUP

B of A Securities analyst Joshua Shanker maintains a Buy rating on Trupanion (NASDAQ:TRUP) and raises the price target from $47 to $56.

Portfolio Pulse from Benzinga Newsdesk

September 20, 2024 | 12:30 pm

CWEN

Jefferies has initiated coverage on Clearway Energy (NYSE:CWEN) with a Buy rating and set a price target of $35.

Portfolio Pulse from Benzinga Newsdesk

September 20, 2024 | 12:26 pm

ASMB

Jefferies analyst Dennis Ding has upgraded Assembly Biosciences (NASDAQ:ASMB) from Hold to Buy, significantly raising the price target from $2 to $35.

Portfolio Pulse from Benzinga Newsdesk

September 20, 2024 | 12:24 pm

LEN

Wedbush analyst Jay McCanless has reiterated a Neutral rating on Lennar (NYSE:LEN) and maintained a price target of $144.

Portfolio Pulse from Benzinga Newsdesk

September 20, 2024 | 12:15 pm